Since SLC25A38 is thought to be a transporter of glycine, which is a substrate for ALAS2 in the first step of heme synthesis, the pathology of CSA due to mutation of this gene is similar to that of XLSA. Here, ALAS2 is linked to X-linked sideroblastic anemia 1.